MYC and cancer: In cancer, on the other hand, MYC is frequently deregulated through different mechanisms including aberrant signal transduction leading to increased MYC transcription or increased MYC mRNA and protein stability, amplifications, chromosomal translocations, and altered enhancer activity [114, 115].